Abstract
Acute lymphoblastic leukemia (ALL) is the most common type of cancer in childhood. Methotrexate (MTX) is one of the main drugs used in treatment, whose mechanism of action is attributed to the inhibition of nucleotide synthesis - leading the leukemic blasts to apoptosis. However, some patients are resistant to treatment with MTX and may undergo a disease relapse; cure rates for these pati…